Sylvaine is the Vice President, Oncology Scientific Innovation at Johnson & Johnson Innovation in California. In this role, she is responsible for creating and implementing an external innovation plan focused on developing an industry-leading portfolio of oncology investment opportunities on the West Coast. She has significant experience in the fields of cancer biology and metabolism, with more than 16 years in research and drug discovery in both pharma and biotech.
Don't miss the companion seminar:
Daria Mochly-Rosen, The George D. Smith Professor in Translational Medicine, Stanford University
"From Bio-X to BioSTAR and beyond – the SPARK At Stanford way. Finding a path to developing a treatment for neurodegenerative diseases", October 23rd, 2018 at 4:00 PM in Clark S361